packageRiamilovir

riamilovir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Riamilovir (Triazavirin) is an investigational antiviral drug being studied for the treatment of viral infections. It is not an approved medicine in the European Union and remains under investigation.

Summary written by glm-5.3-flash from Wikidata Q4462924 and the WHO ATC classification; not checked by a person.

name:riamilovir
ATC codes:J05AX32
DrugBank:DB15622
PubChem CID:3113817
Wikidata:Q4462924
formula:C5H4N6O3S
molar mass:228.186 g/mol (PubChem CID 3113817)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown